Evaluation of a sequential 5-FU and hydroxyurea combination in advanced bowel cancer

A. K. Kao; F. M. Muggia; N. Dubin; W. A. Lerner; R. Stark; J. C. Wernz; J. L. Speyer; R. H. Blum

Evaluation of a sequential 5-FU and hydroxyurea combination in advanced bowel cancer

A. K. Kao
, F. M. Muggia
, N. Dubin
, W. A. Lerner
, R. Stark
, J. C. Wernz
, J. L. Speyer
, R. H. Blum

Research output: Contribution to journal › Article › peer-review

14 Scopus citations

Abstract

Twenty-nine patients (two with small bowel cancer and 27 with colorectal cancer) were treated with a sequential 5-FU-hydroxyurea combination following the suggestion of schedule-dependent synergism in experimental systems. No enhanced toxicity was observed, but the response rate was only 4%. Seven additional patients manifested ≥ 50% declines in CEA, but caution must be used in interpreting such changes as antitumor activity.

Original language	English
Pages (from-to)	1383-1385
Number of pages	3
Journal	Cancer Treatment Reports
Volume	68
Issue number	11
State	Published - 1984

Cite this

@article{f86627ba89df4cedbd68756074895170,

title = "Evaluation of a sequential 5-FU and hydroxyurea combination in advanced bowel cancer",

abstract = "Twenty-nine patients (two with small bowel cancer and 27 with colorectal cancer) were treated with a sequential 5-FU-hydroxyurea combination following the suggestion of schedule-dependent synergism in experimental systems. No enhanced toxicity was observed, but the response rate was only 4\%. Seven additional patients manifested ≥ 50\% declines in CEA, but caution must be used in interpreting such changes as antitumor activity.",

author = "Kao, \{A. K.\} and Muggia, \{F. M.\} and N. Dubin and Lerner, \{W. A.\} and R. Stark and Wernz, \{J. C.\} and Speyer, \{J. L.\} and Blum, \{R. H.\}",

year = "1984",

language = "English",

volume = "68",

pages = "1383--1385",

journal = "Cancer Treatment Reports",

issn = "0361-5960",

publisher = "U.S. National Cancer Institute",

number = "11",

}

TY - JOUR

T1 - Evaluation of a sequential 5-FU and hydroxyurea combination in advanced bowel cancer

AU - Kao, A. K.

AU - Muggia, F. M.

AU - Dubin, N.

AU - Lerner, W. A.

AU - Stark, R.

AU - Wernz, J. C.

AU - Speyer, J. L.

AU - Blum, R. H.

PY - 1984

Y1 - 1984

N2 - Twenty-nine patients (two with small bowel cancer and 27 with colorectal cancer) were treated with a sequential 5-FU-hydroxyurea combination following the suggestion of schedule-dependent synergism in experimental systems. No enhanced toxicity was observed, but the response rate was only 4%. Seven additional patients manifested ≥ 50% declines in CEA, but caution must be used in interpreting such changes as antitumor activity.

AB - Twenty-nine patients (two with small bowel cancer and 27 with colorectal cancer) were treated with a sequential 5-FU-hydroxyurea combination following the suggestion of schedule-dependent synergism in experimental systems. No enhanced toxicity was observed, but the response rate was only 4%. Seven additional patients manifested ≥ 50% declines in CEA, but caution must be used in interpreting such changes as antitumor activity.

UR - https://www.scopus.com/pages/publications/0021733916

M3 - Article

C2 - 6498854

AN - SCOPUS:0021733916

SN - 0361-5960

VL - 68

SP - 1383

EP - 1385

JO - Cancer Treatment Reports

JF - Cancer Treatment Reports

IS - 11

ER -

Evaluation of a sequential 5-FU and hydroxyurea combination in advanced bowel cancer

Abstract

Fingerprint

Cite this